| 2024-06-18 |
详情>>
股本变动：
变动后总股本2006.84万股
|
| 2024-06-18 |
详情>>
业绩披露：
2023年年报每股收益-23.53美元,归母净利润-2.24亿美元,同比去年增长14.14%
|
| 2024-04-01 |
财报披露：
美东时间 2024-04-01 盘后发布财报
|
| 2023-11-21 |
详情>>
业绩披露：
2023年三季报(累计)每股收益-19.68美元,归母净利润-1.83亿美元,同比去年增长-76.31%
|
| 2023-11-09 |
股东大会：
将于2023-12-22召开股东大会
会议内容 ▼▲
- 1.Elect the five directors named in the attached Proxy Statement to serve for a one-year term to expire at the 2024 Annual Meeting of Stockholders or until their respective successors are duly elected and qualified, as follows: five directors, including Alfred P. Poor, Shane McMahon, James Cassano, Andrea Hayward and Paul Hancock to be elected by the holders of the Company’s Common Stock and Series A, Series B, and Series C Preferred Stock, voting together as a single class;
2.Ratify the appointment of Grassi & Co., CPAs, P.C. (“Grassi”) as the independent registered accounting firm of the Company for the fiscal year ending December 31, 2023;
3.Approval of the amendment and restatement of our 2010 Equity Incentive Plan, a copy of such amended and restated plan is included as Appendix A to this proxy statement (the “Plan”), to increase the number of shares authorized for issuance under the Plan to 37,500,00;
4.Approval of the issuance of common shares as the underlying conversion of preferred Series C shares accordance with Nasdaq Rules Rule 5635(d);
5.Approval of the issuance of securities in one or more non-public offerings where the maximum discount at which securities will be offered will be equivalent to a discount of 20% below the market price of our shares of Common Stock, or such lower amount as permitted by Nasdaq, in accordance with Nasdaq Listing Rules 5635(b) and 5635(d);
6.To approve the amendment of the Company’s Second Amended and Restated Certificate of Incorporation to increase the total number of shares of the Company’s authorized common stock and preferred stock;
7.To approve the potential issuance of more than 20% of the Company’s outstanding shares of common stock to Yorkville Advisors upon the conversion of the Debenture(s) and preferred stock that were issued in financing transactions, and in accordance with the stockholder approval requirement of Nasdaq Listing Rules 5635(b) and 5635(d).
8.Approval of the adjournment of the Annual Meeting, if necessary or advisable, to solicit additional proxies in favor of the foregoing proposals if there are not sufficient votes to approve the foregoing proposals;
9.Transact such other business as may properly come before the meeting or any adjournment or postponement thereof.
|
| 2023-08-25 |
详情>>
拆分方案：
每250.0000合并分成2.0000股
|
| 2023-08-25 |
详情>>
业绩披露：
2023年中报每股收益-14.84美元,归母净利润-1.2亿美元,同比去年增长-80.77%
|
| 2023-08-04 |
详情>>
业绩披露：
2023年一季报每股收益-0.12美元,归母净利润-8431.7万美元,同比去年增长-195.72%
|
| 2023-05-30 |
股东大会：
将于2023-06-16召开股东大会
会议内容 ▼▲
- 1.Registration of participating shareholders; election of a person to chair the Meeting and a person to cosign the minutes.
2.Approval of the notice and the agenda of the Meeting.
3.Private Placement; Issuance of Tranche 2 Shares and amendment of articles of association.
4.Renewal of the Board authorization to increase the Company’s share capital by issuance of new shares.
5.Board election and Board remuneration.
|
| 2023-03-30 |
详情>>
业绩披露：
2020年年报每股收益-0.47美元,归母净利润-1.01亿美元,同比去年增长-2.8%
|
| 2023-03-30 |
详情>>
业绩披露：
2022年年报每股收益-0.51美元,归母净利润-2.61亿美元,同比去年增长-1.83%
|
| 2022-11-23 |
股东大会：
将于2022-12-09召开股东大会
会议内容 ▼▲
- 1.Registration of participating shareholders; election of a person to chair the Meeting and a person to cosign the minutes.
2.Approval of the notice and the agenda of the Meeting.
3.Private Placement; Issuance of Tranche 2 Shares and amendment of articles of association.
4.Renewal of the Board authorization to increase the Company’s share capital by issuance of new shares.
|
| 2022-11-09 |
详情>>
业绩披露：
2022年三季报(累计)每股收益-0.21美元,归母净利润-1.04亿美元,同比去年增长-60.7%
|
| 2022-10-21 |
股东大会：
将于2022-11-16召开股东大会
会议内容 ▼▲
- 1.Elect the five directors named in the attached Proxy Statement to serve for a one-year term to expire at the 2022 Annual Meeting of Stockholders or until their respective successors are duly elected and qualified, as follows: five directors, including Alfred P. Poor, Shane McMahon, James S. Cassano, Jerry Fan, and Harry Edelson to be elected by the holders of the Company’s Common Stock and Series A preferred stock, voting together as a single class;
2.Ratify the appointment of Grassi & Co., CPAs, P.C. (“Grassi”) as the independent registered accounting firm of the Company for the fiscal year ending December 31, 2022;
3.Approval of the amendment and restatement of our 2010 Equity Incentive Plan, a copy of such amended and restated plan is included as Appendix A to this proxy statement (the “Plan”), to increase the number of shares authorized for issuance under the Plan to 120,000,000;
4.Approval of the issuance of shares of common stock to Yorkville Advisors pursuant to the terms of a standby equity purchase agreement (the “SEPA”) included as Appendix B to this Proxy Statement, with such modifications, amendments, or changes (consistent with the intent and purpose of this proposal) agreed upon by the parties to the SEPA, and in accordance with the stockholder approval requirements of the Nasdaq Listing Rules 5635(b) and 5635(d);
5.Approval of an advisory (non-binding) resolution regarding the compensation of our named executive officers;
6.Approval of an advisory (non-binding) vote on the frequency at which the Company should include an advisory vote regarding the compensation of our named executive officers in its future proxy statements for stockholder consideration;
7.Approval of the issuance of securities in one or more non-public offerings where the maximum discount at which securities will be offered will be equivalent to a discount of 20% below the market price of our shares of Common Stock, in accordance with Nasdaq Listing Rules 5635(b) and 5635(d);
8.Approval of the adjournment of the Annual Meeting, if necessary or advisable, to solicit additional proxies in favor of the foregoing proposals if there are not sufficient votes to approve the foregoing proposals;
9.Transact such other business as may properly come before the meeting or any adjournment or postponement thereof.
|
| 2022-09-09 |
详情>>
业绩披露：
2022年中报每股收益-0.13美元,归母净利润-6627.8万美元,同比去年增长-402.94%
|
| 2022-09-09 |
详情>>
业绩披露：
2022年一季报每股收益-0.06美元,归母净利润-2851.2万美元,同比去年增长-339.86%
|
| 2022-09-02 |
详情>>
业绩披露：
2021年年报每股收益-0.57美元,归母净利润-2.56亿美元,同比去年增长-152.82%
|
| 2021-11-12 |
股东大会：
将于2021-12-22召开股东大会
会议内容 ▼▲
- 1.Elect the five directors named in the attached Proxy Statement to serve for a one-year term to expire at the 2021 Annual Meeting of Shareholders or until their respective successors are duly elected and qualified, as follows: five directors, including Alfred P. Poor, Shane McMahon, James S. Cassano, Jerry Fan, and Harry Edelson to be elected by the holders of the Company’s common stock and Series A preferred stock, voting together as a single class;
2.Ratify the appointment of BDO USA, LLP as the independent registered accounting firm of the Company for the fiscal year ending December 31, 2021;
3.Transact such other business as may properly come before the meeting or any adjournment or postponement thereof.
|
| 2021-09-06 |
温馨提示：
美股因劳工节，9月6日休市一天
|
| 2020-09-18 |
股东大会：
将于2020-10-22召开股东大会
会议内容 ▼▲
- 1.Elect the seven directors named in the attached Proxy Statement to serve for a one-year term to expire at the 2020 Annual Meeting of Shareholders or until their respective successors are duly elected and qualified, as follows: seven directors, including Bruno Wu, Alfred Poor, Shane McMahon, James Cassano, Jerry Fan, Chao Yang, and Harry Edelson to be elected by the holders of the Company’s common stock and Series A preferred stock, voting together as a single class;
2.Ratify the appointment of BF Borgers CPA PC as the independent registered accounting firm of the Company for the fiscal year ending December 31, 2020;
3.Approval of the amendment and restatement of our 2010 Equity Incentive Plan, a copy of such amended and restated plan is included as Appendix A to this Proxy Statement (the “Plan”), to increase the number of shares authorized for issuance under the Plan to 56,800,000 and so that the term of the Plan shall be until August 31, 2030;
4.Approval of the issuance of shares of common stock to Yorkville Advisors pursuant to the terms of a standby equity distribution agreement included as Appendix B to this Proxy Statement in accordance with the stockholder approval requirements of NASDAQ listing rule 5635(d);
5.Transact such other business as may properly come before the meeting or any adjournment or postponement thereof.
|
| 2019-12-13 |
股东大会：
将于2019-12-30召开股东大会
会议内容 ▼▲
- 1.Elect the nine directors named in the attached Proxy Statement to serve for a one-year term to expire at the 2020 Annual Meeting of Shareholders or until their respective successors are duly elected and qualified, as follows: seven directors, including Bruno Wu, Alfred Poor, Shane McMahon, James Cassano, Jerry Fan, Chao Yang, John Wallace, Harry Edelson and Steven Fadem to be elected by the holders of the Company’s common stock and Series A preferred stock, voting together as a single class;
2.Ratify the appointment of BF Borgers CPA PC as the independent registered accounting firm of the Company for the fiscal year ending December 31, 2019;
3.Transact such other business as may properly come before the meeting or any adjournment or postponement thereof.
|
| 2018-12-14 |
股东大会：
将于2018-12-28召开股东大会
会议内容 ▼▲
- 1.Elect the nine directors named in the attached Proxy Statement to serve for a one-year term to expire at the 2019 Annual Meeting of Shareholders or until their respective successors are duly elected and qualified, as follows: seven directors, including Shane McMahon, James Cassano, Jerry Fan, Jin Shi, Brett McGonegal, Richard Frankel, Kang Zhao, Alfred Poor and Chao Yang to be elected by the holders of the Company’s common stock and Series A preferred stock, voting together as a single class;
2.Ratify the appointment of BF Borgers CPA PC as the independent registered accounting firm of the Company for the fiscal year ending December 31, 2018;
3.Transact such other business as may properly come before the meeting or any adjournment or postponement thereof.
|
| 2017-11-20 |
股东大会：
将于2017-12-20召开股东大会
会议内容 ▼▲
- 1.Elect the seven directors named in the attached Proxy Statement to serve for a one-year term to expire at the 2018 Annual Meeting of Shareholders or until their respective successors are duly elected and qualified, as follows: seven directors, including Bruno Wu, Shane McMahon, Robert Benya, James Cassano, Jerry Fan, Jin Shi and Xin Wang to be elected by the holders of the Company’s common stock and Series A preferred stock, voting together as a single class;
2.Ratify the appointment of Grant Thornton LLP as the independent registered accounting firm of the Company for the fiscal year ending December 31, 2017;
3.Transact such other business as may properly come before the meeting or any adjournment or postponement thereof.
|
| 2016-05-17 |
股东大会：
将于2016-06-27召开股东大会
会议内容 ▼▲
- 1.Elect the eight directors named in the attached Proxy Statement to serve for a one-year term to expire at the 2017 Annual Meeting of Shareholders or until their respective successors are duly elected and qualified, as follows:
a.Seven directors, including Bruno Wu, Shane McMahon, Mingcheng Tao, James Cassano, Jerry Fan, Jin Shi and Polly Wang to be elected by the holders of the Company’s common stock, Series A preferred stock and Series E preferred stock, voting together as a single class;
b.One director, Xuesong Song, to be elected by the holders of the Company’s Series E preferred stock, voting as a separate class;
2.Approve of the issuance of (i) up to 1,818,182 shares of our common stock, at an exercise price of $2.75 per share under 2-year warrant held by Beijing Sun Seven Stars Culture Development Limited, a PRC company (“SSS”), (ii) 9,208,860 shares of our common stock issuable upon the conversion of a promissory note held by SSS, and (iii) up to 15,000,000 shares of our common stock (5,000,000 shares of our common stock for each of 2016, 2017 and 2018), with the exact amount based on an earn-out provision under the terms of a Share Purchase Agreement with Tianjin Enternet Network Technology Limited, a PRC company (“Tianjin”), an affiliate of SSS, to the extent such issuances would result in (i) SSS and its affiliates acquiring an aggregate number of shares of our common stock equal to or exceeding 20% of the outstanding shares of our common stock and (ii) have, or will have upon issuance, voting power equal to or in excess of 20% of the voting power outstanding;
3.Ratify the appointment of KPMG Huazhen LLP as the independent registered accounting firm of the Company for the fiscal year ending December 31, 2016;
4.Transact such other business as may properly come before the meeting or any adjournment or postponement thereof.
|
| 2015-12-09 |
股东大会：
将于2015-12-29召开股东大会
会议内容 ▼▲
- (1)Elect the five directors named in the attached Proxy Statement to serve for one-year term to expire at the 2016 annual meeting of stockholders or until their respective successors are duly elected and qualified, as follows:
(a)four directors, including, Shane McMahon, James S. Cassano, Jin Shi and Arthur Wong to be elected by the holders of the Company’s common stock, Series A preferred stock and Series E preferred stock, voting together as a single class;
(b)one director, Xuesong Song, to be elected by the holders of the Company’s Series E preferred stock, voting as a separate class;
(2)Approve (i) the issuance of 4,545,454 shares of our common stock for a purchase price of $2.20 per share, 2-year warrants to acquire an additional 1,818,182 shares of our common stock, at an exercise price of $2.75 per share, and 9,208,860 shares of our common stock, to Beijing Sun Seven Stars Culture Development Limited, a PRC company (“SSS”), and (ii) the issuance of up to 15,000,000 shares of our common stock (5,000,000 shares of our common stock for each of 2016, 2017 and 2018) to Tianjin Enternet Network Technology Limited, a PRC Company (“Tianjin”), an affiliate of SSS, and (iii) the potential change in control of the Company that could result due to such issuances.
(3)Ratify the appointment of “KPMG Huazhen LLP (formerly known as KPMG Huazhen (Special General Partnership))” as the independent registered public accounting firm of the Company for the fiscal year ending December 31, 2015;
(4)Transact such other business as may properly come before the meeting or any adjournment or postponement thereof.
|
| 2015-06-12 |
详情>>
内部人交易：
Wong Arthur Lap Tat股份增加7298.00股
|
| 2014-10-27 |
股东大会：
将于2014-11-20召开股东大会
会议内容 ▼▲
- 1.Elect the seven directors named in the attached Proxy Statement to serve for one-year term to expire at the 2015 annual meeting of stockholders or until their respective successors are duly elected and qualified, as follows:
a.six directors, including, Shane McMahon, Weicheng Liu, James S. Cassano, Clifford Higgerson, Jin Shi and Arthur Wong to be elected by the holders of the Company’s common stock, Series A preferred stock and Series E preferred stock, voting together as a single class;
b.one director, Xuesong Song, to be elected by the holders of the Company’s Series E preferred stock, voting as a separate class;
2.Ratify the appointment of KPMG Huazhen (Special General Partnership) as the independent registered public accounting firm of the Company for the fiscal year ending December 31;
3.Consider and approve an advisory (non-binding) resolution regarding the compensation of our named executive officers;
4.Consider and act upon an advisory (non-binding) vote on the frequency at which the Company should include an advisory vote regarding the compensation of our named executive officers in its future proxy statements for stockholder consideration;
5.Transact such other business as may properly come before the meeting or any adjournment or postponement thereof.
|
| 2013-11-08 |
复牌提示：
2013-11-08 08:10:03 停牌，复牌日期 2013-11-08 08:45:00
|